A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients

被引：0
|
作者：
Forlano, Roberta [1 ]
Mullish, Benjamin H. [1 ]
Blanco, Jesus Miguens [1 ]
Danckert, Nathan [1 ]
Thursz, Mark [1 ]
Manousou, Pinelopi [1 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-950
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [41] MicroRNA expression fingerprint in serum of type 1 diabetic patients
    Sebastiani, G.
    Spagnuolo, I.
    Patti, A.
    Grieco, F. A.
    Cataldo, D.
    Ferretti, E.
    Tiberti, C.
    Dotta, F.
    DIABETOLOGIA, 2012, 55 : S48 - S48
  • [42] Myosteatosis and sarcopenia are prevalent in patients with NAFLD even in the absence of advanced fibrosis
    Pallini, Giada
    Prat, Laura Iogna
    Roccarina, Davide
    Arico', Francesco
    Mantovani, Anna
    Vespa, Edoardo
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S149 - S150
  • [43] MACHINE LEARNING ALGORITHMS FOR PREDICTION OF NASH AND ADVANCED FIBROSIS IN NAFLD PATIENTS
    Kosick, Heather M.
    McIntosh, Chris
    Fakhriyehasl, Mina
    Bera, Chinmay
    Adeyi, Oyedele
    Jhaveri, Kartik
    Patel, Keyur
    GASTROENTEROLOGY, 2022, 162 (07) : S1293 - S1294
  • [44] Serum Ferritin Concentration May Predict Waiting List Mortality: Evaluation of a Cohort of 1776 Patients
    Al-Freah, Mohammad A. B.
    Kriese, Stephen
    Foxton, Matthew
    Bernal, William
    Auzinger, Georg
    Aluvihare, Varuna
    Suddle, Abid
    Agarwal, Kosh
    Heaton, Nigel D.
    Rela, Mohamed
    Wendon, Julia A.
    O'Grady, John G.
    Heneghan, Michael A.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S277 - S277
  • [45] Elevated hepatic and adipose hepcidin expression in patients with advanced NAFLD fibrosis
    Ryan, J. D.
    Watson, M.
    Cargill, T.
    Rickers, L.
    Fletcher, C.
    Foliaki, A.
    Kalogeropoulos, G.
    Tomlinson, J. W.
    Gillies, R.
    Sgromo, B.
    Cobbold, J. F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S431 - S431
  • [46] PANEL OF SERUM BIOMARKERS MAY PREDICT BENEFIT FROM BEVACIZUMAB (BEV) IN ADVANCED NSCLC PATIENTS
    Braun, Eduardo
    Fidler, Mary Jo
    Basu, Sanjib
    Gargaram, Anjali
    Walters, Kelly
    Fhied, Cristina
    Borgia, Jeffrey A.
    Bonomi, Philip D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S124 - S125
  • [47] Panel of Serum Biomarkers May Predict Benefit from Bevacizumab (BEV) in Advanced NSCLC Patients
    Braun, E.
    Fidler, M.
    Basu, S.
    Gangaram, A.
    Walters, K. Kaiser
    Karmali, R.
    Fhied, C.
    Borgia, J. A.
    Bonomi, P. D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S219 - S219
  • [48] Relationship of BMI and the metabolic syndrome in non-diabetic patients with NAFLD
    Nelson, James e
    Yates, Katherine
    Uenalp, Aynur
    Kowdley, Kris V.
    HEPATOLOGY, 2007, 46 (04) : 742A - 742A
  • [49] Performance of serum CD163 as a marker of fibrosis in patients with NAFLD
    Ragab, Halla M.
    Abd El Maksoud, Nabila
    Amin, Mona A.
    Elaziz, Wafaa Abd
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (01) : 87 - 92
  • [50] Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy
    Zhang, Junlin
    Wang, Yiting
    Li, Li
    Zhang, Rui
    Guo, Ruikun
    Li, Hanyu
    Han, Qianqian
    Teng, Geer
    Liu, Fang
    RENAL FAILURE, 2018, 40 (01) : 243 - 251
12345